Business Development Manager

Moligo Technologies AB; Stockholms kommun; Hybrid; SEK 550,000 - 820,000; Full time

Job summary

Moligo Technologies AB is seeking an experienced Business Development Manager to drive commercial growth in the synthetic DNA and oligonucleotide reagent space. The role is hybrid/flexible in the Stockholm area, with global client-facing responsibilities across biotech, pharma, diagnostics, and life sciences tools.

You will identify and develop opportunities, build and manage a pipeline from lead generation to contract close, and negotiate MTAs or supply agreements in collaboration with legal

Qualifications

• Track record of building pipeline and closing deals in a scientific/technical B2B environment.
• Strong negotiation skills, including experience with MTAs, supply agreements, or long-term commercial contracts.
• Excellent communication skills in English; additional languages a plus.
• Willingness to travel internationally (conferences, client visits, primarily US and Europe).
• Self-starter mentality suited to a fast-growing, entrepreneurial company environment.
• Bachelor’s degree in a life sciences discipline required; advanced degree (MSc/PhD) or MBA a plus but not required.

Responsibilities

• Identify, prioritize, and develop new business opportunities among biotech, pharma, CDMO/CRO, and diagnostics companies.
• Build and manage a pipeline of prospective clients from lead generation through contract negotiation and close.
• Represent the company at industry conferences, trade shows, and scientific meetings (e.g., ASGCT, ESGCT, SynBioBeta, TIDES, CRISPRMED).
• Develop and maintain relationships with key accounts, including R&D, procurement, and supply chain stakeholders.
• Collaborate closely with process development, technical/scientific teams, and leadership to align commercial strategy with manufacturing capacity and technical capabilities.
• Negotiate commercial terms, pricing structures, and MTAs or supply agreements in partnership with legal and technical teams.
• Track and report on market trends, competitor activity, and customer needs across the long ssDNA, oligonucleotide, and broader nucleic acid manufacturing landscape.
• Support development of marketing materials, pitch decks, and investor-facing commercial narratives as needed.
• Meet or exceed revenue and pipeline growth targets.

Skills

Pipeline development

Negotiation skills

English communication

International travel

Self-starter

Strategic thinking

Education

Bachelors in life sciences

MSc/PhD or MBA a plus

Job description

Business Development Manager

Location: Stockholm area, Sweden (hybrid/flexible) | Full-time

About the Role

We are looking for an experienced Business Development Manager to drive commercial growth in the synthetic DNA and oligonucleotide reagent space. This is a high-impact, client-facing role suited to someone who thrives at the intersection of science and sales, comfortable discussing molecular biology applications with R&D scientists one day and negotiating supply agreements with procurement teams the next.

You’ll be responsible for expanding our footprint among biotech, pharma, diagnostics, and life sciences tool companies, particularly across the US and European markets, as demand grows for high-quality linear and circular single-stranded DNA (ssDNA) used in gene editing, cell therapy, diagnostics, and synthetic biology applications.

Qualifications

Track record of building pipeline and closing deals in a scientific/technical B2B environment.

Strong negotiation skills, including experience with MTAs, supply agreements, or long-term commercial contracts.

Excellent communication skills in English; additional languages a plus.

Willingness to travel internationally (conferences, client visits, primarily US and Europe).

Self-starter mentality suited to a fast-growing, entrepreneurial company environment.

Bachelor’s degree in a life sciences discipline required; advanced degree (MSc/PhD) or MBA a plus but not required.

Nice to Have

• Familiarity with ssDNA production technologies, oligonucleotide synthesis, or plasmid/DNA manufacturing
• Prior experience at a synthetic DNA, oligo, or nucleic acid reagent supplier
• Existing relationships with gene editing, cell therapy, or diagnostics companies

Why Join Us

This is an opportunity to join a growing company at the forefront of ssDNA and oligonucleotide manufacturing, playing a direct role in shaping our commercial strategy as we scale internationally. You’ll work closely with a lean, technically strong leadership team and have real ownership over how we grow our client base.

What You’ll Do

Identify, prioritize, and develop new business opportunities among biotech, pharma, CDMO/CRO, and diagnostics companies.

Build and manage a pipeline of prospective clients from lead generation through contract negotiation and close.

Represent the company at industry conferences, trade shows, and scientific meetings (e.g., ASGCT, ESGCT, SynBioBeta, TIDES, CRISPRMED).

Develop and maintain relationships with key accounts, including R&D, procurement, and supply chain stakeholders.

Collaborate closely with process development, technical/scientific teams, and leadership to align commercial strategy with manufacturing capacity and technical capabilities.

Negotiate commercial terms, pricing structures, and Material Transfer Agreements (MTAs) or supply agreements in partnership with legal and technical teams.

Track and report on market trends, competitor activity, and customer needs across the long ssDNA, oligonucleotide, and broader nucleic acid manufacturing landscape.

Support development of marketing materials, pitch decks, and investor-facing commercial narratives as needed.

Meet or exceed revenue and pipeline growth targets.

What We're Looking For

5+ years of business development, sales, or commercial experience in life sciences, ideally within CDMO/CRO, synthetic biology, genomics, or nucleic acid manufacturing.

Existing network of contacts among biotech, pharma, or diagnostics companies is a strong plus.

Solid scientific literacy: comfortable discussing molecular biology, gene editing (CRISPR), cell and gene therapy, or synthetic biology applications with technical stakeholders.